SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-014651
Filing Date
2020-04-01
Accepted
2020-04-01 07:30:35
Documents
14
Period of Report
2020-04-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flxn-8k_20200401.htm   iXBRL 8-K 52348
2 EX-99.1 flxn-ex991_6.htm EX-99.1 43301
3 GRAPHIC gm2ej3f4duun000001.jpg GRAPHIC 126974
  Complete submission text file 0001564590-20-014651.txt   412399

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200401.xsd EX-101.SCH 5804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200401_lab.xml EX-101.LAB 19474
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200401_pre.xml EX-101.PRE 11651
11 EXTRACTED XBRL INSTANCE DOCUMENT flxn-8k_20200401_htm.xml XML 3546
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 20763727
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences